Plasma-lyte 148 clinical trials
How each study uses Plasma-lyte 148 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 7
The George Institute (2) · Children's Hospital of Philadelphia (1) · The University of Queensland (1) · Hospital do Coracao (1) · Algemeen Ziekenhuis Maria Middelares (1) · Regional Hospital Holstebro (1)
Often tested with
Tested in the same studies.
Sodium Chloride (2) · Ringer's Lactate (1) · Norepinephrine (1)
Studies
Open first, then newest update. How each study uses Plasma-lyte 148 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Goal-directed Fluid Therapy During Deep Inferior Epigastric Perforator (DIEP) Free Flap Breast ReconstructionTerminatedPhase 4Algemeen Ziekenhuis Maria MiddelaresNCT06080178Written as Plasma-lyte (static group)
- Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosisCompletedPhase 3The George InstituteNCT05752279Written as Plasma-Lyte 148
- Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in SepsisCompletedPhase 3Children's Hospital of PhiladelphiaNCT04102371Written as Plasma-lyte
- Better Evidence for Selecting Transplant FluidsCompletedPhase 3The University of QueenslandNCT03829488Written as Plasma-Lyte 148 (approx. pH 7.4) IV Infusion
- Plasma-Lyte 148® versUs Saline StudyCompletedPhase 4The George InstituteNCT02721654Written as Plasma-Lyte 148®
- Balanced Solution Versus Saline in Intensive Care StudyCompletedPhase 3Hospital do CoracaoNCT02875873Written as Plasma-Lyte
- 0,9% NaCl Effect on Kidney Function and Glycocalyx in Patients Operated on for Primary HiparthrosisStatus unknownPhase 4Regional Hospital HolstebroNCT02528448Written as Plasma-lyte
Given beside what is tested · 2 — Plasma-lyte 148 is usual care or a partner of the new treatment
- Using Vasopressor Medication to Support Blood Pressure During Intubation ProcedureCompletedPhase 3Wright State UniversityNCT05355974Written as Plasma-lyte
- Decision Support for Intraoperative Low Blood PressureCompletedNot applicableVanderbilt University Medical CenterNCT02726620Written as Plasma-Lyte
Codes
What other systems call Plasma-lyte 148 · ClinicalTrials.gg INT002552
- MeSH (NLM) C012499Plasma-lyte 148One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C012499 | Plasma-lyte 148 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.